4//SEC Filing
Jaen Juan C. 4
Accession 0001422996-25-000009
CIK 0001724521other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:39 PM ET
Size
10.0 KB
Accession
0001422996-25-000009
Insider Transaction Report
Form 4
Jaen Juan C.
President
Transactions
- Sale
Common Stock
2025-11-18$19.75/sh−5,050$99,738→ 1,037,060 total(indirect: By Trust) - Sale
Common Stock
2025-11-17$20.23/sh−37,114$750,720→ 1,049,946 total(indirect: By Trust) - Sale
Common Stock
2025-11-17$20.71/sh−7,836$162,307→ 1,042,110 total(indirect: By Trust)
Holdings
- 367,220
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001422996
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:39 PM ET
- Size
- 10.0 KB